Latest filing: Shareholders meeting - Alkem Laboratories Limited
ObservedCompany dossier
Alkem Laboratories
NSE:ALKEM · ISIN INE540L01014
- Close
- ₹5,672.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Alkem Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹3,603.3 Cr · PAT ₹251.1 Cr.
Exchange XBRLLatest ownership: promoter group 49.70% and public 50.30% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Alkem Laboratories Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Shareholders meeting - Alkem Laboratories Limited
NSE · exchange filing
Observed
Source filing Alkem Laboratories Ltd - 539523 - Notice Of 52Nd Annual General Meeting And Annual Report For FY 2025-26.
BSE · annual report
Observed
Source filing General Updates - Alkem Laboratories Limited
NSE · exchange filing
Observed
Source filing Alkem Laboratories Ltd - 539523 - Business Responsibility and Sustainability Reporting (BRSR)
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹3,603.3 Cr
- Profit after tax
- ₹251.1 Cr
- EPS
- ₹19.77
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 49.70%
- Public
- 50.30%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL